The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
تاريخ النشر : 2020-12-10 23:19:59
عدد المشاهدات : 12
تاريخ النشر : 2020-12-10 23:19:59
عدد المشاهدات : 12
The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth | Research Topic |
كرم الله شاكر | Researcher Name |
Oncotarget | Journal Name |
Impact Journals, LLC | Publisher |
3815–3829 | ISSN |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790502/ | DOI |